cas 1040671-70-2|| where to buy N-{4-[6-(azepan-1-yl)pyridazin-3-yl]phenyl}-2,5-difluorobenzene-1-sulfonamide

Nom du produit:N-{4-[6-(azepan-1-yl)pyridazin-3-yl]phenyl}-2,5-difluorobenzene-1-sulfonamide

IUPAC Name:N-{4-[6-(azepan-1-yl)pyridazin-3-yl]phenyl}-2,5-difluorobenzene-1-sulfonamide

: CAS：1040671-70-2; Formule moléculaire：C22H22F2N4O2S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1040671-70-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1040671-70-2; Formule moléculaire:C22H22F2N4O2S; Point de fusion:-; Code SMILES:FC1=CC(=C(F)C=C1)S(=O)(=O)NC1=CC=C(C=C1)C1=CC=C(N=N1)N1CCCCCC1; Densité:

: Numéro de catalogue:CM1008525; Poids moléculaire:444.5; Point d'ébullition:; N° Mdl:; Stockage:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.